ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,966.80
      0.37%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.095
      -0.37%
      Bitcoin
      57,559.12
      1.50%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS

      Emergent Biosolutions (EBS)

      Emergent Biosolutions Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:EBS
      DateTimeSourceHeadlineSymbolCompany
      01/14/20226:38AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      01/14/20226:30AMGlobeNewswire Inc.Founder and Executive Chairman of Emergent BioSolutions Announces RetirementNYSE:EBSEmergent Biosolutions Inc
      01/09/20222:00PMGlobeNewswire Inc.Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 ResultsNYSE:EBSEmergent Biosolutions Inc
      01/03/20226:30AMGlobeNewswire Inc.Emergent BioSolutions to Participate in Investor ConferencesNYSE:EBSEmergent Biosolutions Inc
      12/16/20217:30AMGlobeNewswire Inc.Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine CandidateNYSE:EBSEmergent Biosolutions Inc
      12/09/20211:55PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:EBSEmergent Biosolutions Inc
      11/23/202111:40AMTipRanksEmergent Biosolutions: Poised for Higher RevenuesNYSE:EBSEmergent Biosolutions Inc
      11/22/20216:01PMPR Newswire (US)SiTime Set to Join S&P MidCap 400; Emergent BioSolutions to Join S&P SmallCap 600NYSE:EBSEmergent Biosolutions Inc
      11/15/20215:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:EBSEmergent Biosolutions Inc
      11/12/20218:49AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      11/11/20214:05PMGlobeNewswire Inc.Emergent BioSolutions Announces Stock Repurchase ProgramNYSE:EBSEmergent Biosolutions Inc
      11/04/20214:23PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      11/04/20214:16PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      11/04/20214:05PMGlobeNewswire Inc.Emergent BioSolutions Reports Financial Results For Third Quarter 2021NYSE:EBSEmergent Biosolutions Inc
      11/02/20219:00AMGlobeNewswire Inc.BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of DirectorsNYSE:EBSEmergent Biosolutions Inc
      10/18/20214:20PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
      10/18/20214:19PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
      10/18/20214:17PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
      10/18/20214:16PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:EBSEmergent Biosolutions Inc
      10/18/20216:30AMGlobeNewswire Inc.Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021NYSE:EBSEmergent Biosolutions Inc
      10/15/20216:30AMGlobeNewswire Inc.Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLPNYSE:EBSEmergent Biosolutions Inc
      10/01/20216:04AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:EBSEmergent Biosolutions Inc
      09/30/20211:12PMTipRanksEmergent BioSolutions: Reasonable Price Suggests UpsideNYSE:EBSEmergent Biosolutions Inc
      09/21/20211:23PMBusiness WireShuman, Glenn & Stecker Investigates Emergent BioSolutions, Inc.NYSE:EBSEmergent Biosolutions Inc
      09/14/20218:00AMGlobeNewswire Inc.Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-BNYSE:EBSEmergent Biosolutions Inc
      09/09/20214:34PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NYSE:EBSEmergent Biosolutions Inc
      09/09/20215:50AMTipRanksWhat Do Emergent Biosolutions’ Newly Added Risk Factors Tell Investors?NYSE:EBSEmergent Biosolutions Inc
      08/25/20216:30AMGlobeNewswire Inc.Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19NYSE:EBSEmergent Biosolutions Inc
      08/23/20214:05PMGlobeNewswire Inc.Emergent BioSolutions to Participate in Investor ConferencesNYSE:EBSEmergent Biosolutions Inc
      08/09/20214:20PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NYSE:EBSEmergent Biosolutions Inc
       Showing the most relevant articles for your search:NYSE:EBS